Morbidity in Breast Cancer Patients with Sentinel Node Metastases Undergoing Delayed Axillary Lymph Node Dissection (ALND) Compared with Immediate ALND
- 19 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 15 (1), 262-267
- https://doi.org/10.1245/s10434-007-9593-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI Journal of the National Cancer Institute, 2006
- Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled TrialJournal of Clinical Oncology, 2005
- Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionEuropean Journal Of Cancer, 2005
- The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node DissectionAnnals of Surgery, 2004
- Predictors of non-sentinel lymph node metastasis in breast cancer patientsEuropean Journal Of Cancer, 2004
- European studies on breast lymphatic mappingSeminars in Oncology, 2004
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerNew England Journal of Medicine, 2003